News

CPI-444 is a selective and potent inhibitor of the adenosine A2A receptor. The data were presented today in a poster session by John Powderly II, M.D., founder and

CHMP recommended the use of Suliqua in combination with metformin for the treatment of adults with type 2 diabetes mellitus to improve glycemic control when this has not been

The acquisition will mark Eagle’s entry into biologics, the fastest growing sector of the pharmaceuticals market, and will allow the Company to apply its proven market strategy to

The Prospective Randomized Evaluation of CelecoxibIntegrated Safety vs. Ibuprofen Or Naproxen (Precision) demonstrated that Celebrex has similar cardiovascular risk as compared to prescription doses Of Ibuprofen and Naproxen. The findings contradict some of the researchers’ belief

The approval allows the company to use Ibrance in combination with an aromatase inhibitor. It also allows the use of Ibrance in combination with fulvestrant to treat women who

Metformin DR is an investigational product designed to target metformin delivery to the lower small intestine, where it is minimally absorbed yet elicits robust glucose lowering effects. The

Under the terms of the agreement, the companies may elect to supply drug only or supply drug and share development costs on a study-by-study basis. The first study

emlidy has a boxed warning in its product label regarding the risks of lactic acidosis/severe hepatomegaly with steatosis and post-treatment severe acute exacerbation of hepatitis B. See below

Drug resistance contributes to nearly 600,000 cancer deaths in the US per year. The partners will use Watson's computational and machine learning methods to study drug resistance in